feed,title,long_url,short_url
Benzinga,Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech,https://benzinga.com/general/biotech/22/03/26166765/protagonist-therapeutics-earns-25m-milestone-payment-from-janssen-biotech,https://bit.ly/3KN906h
Benzinga,FDA Removes Clinical Hold On AIM ImmunoTech's Mid-Stage Ampligen Trial In Pancreatic Cancer,https://benzinga.com/general/biotech/22/03/26166535/fda-removes-clinical-hold-on-aim-immunotechs-mid-stage-ampligen-trial-in-pancreatic-cancer,https://bit.ly/3u54uJE
